← Leaderboards
Thomas R Gaborski
Simpore, Inc.
$733,029
Attributed
$1,632,724
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $907.7K · FY2015–23$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NSF$1,632,724 · 3
By mechanism
—$1,632,724 · 3
Top collaborators
- James Roussie2 shared
- Karin Wuertz-Kozak1 shared
- Zhen Ma1 shared
Grant awards (3)
FMSG: Bio: Advancing Extracellular Vesicle Biomanufacturing of CRISPR-Edited Human iPSC-derived MSCs with Next-Generation Purification$500,000
· FY2023 · BIO
STTR Phase II: Development of Ultrathin Nanomembranes for Home-based Hemodialysis$907,724
· FY2017 · TIP
STTR Phase I: Development of Ultrathin Nanomembranes for Home-based Hemodialysis$225,000
· FY2015 · TIP